Pulling SEC filings + quote and writing the call…
LGND
LIGAND PHARMACEUTICALS INC
Next earnings Aug 5, 2026 · consensus $2.07 EPS, $64.6M rev
Last earnings -9.6% on 2026-05-07
$274.88
▲ +4.46%$274.88▲ +139.01%
over 1Y
L $112.54EODHDH $274.88
Earnings Dividend Split Congress buy Congress sellFilings colored by tone · hover for detail
Today+4.5%
1W+8.0%
1M+32.3%
3M+30.6%
YTD+44.6%
1Y+139.0%
Hold
Conviction
Horizon
Long (>12mo)
Street · 14 analysts
Buy
Capital-light royalty pharma with a growing royalty stream, but FY2025 earnings lean heavily on lumpy investment gains.
The read
Sources: SEC EDGAR (CIK 0000886163, latest 10-Q filed 2026-05-08) · EODHD · analysis by claude-code · as of 6/21/2026, 8:55:13 PM.
Research and education only — not financial advice. Calls are generated from SEC filings and a delayed/third-party price feed, may be wrong or out of date, and are not a recommendation to buy or sell any security. Do your own research.